BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12515810)

  • 1. CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.
    Vacchio MS; Hodes RJ
    J Exp Med; 2003 Jan; 197(1):19-26. PubMed ID: 12515810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
    J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for CD28 in thymic selection: elimination of CD28/B7 interactions increases positive selection.
    Vacchio MS; Williams JA; Hodes RJ
    Eur J Immunol; 2005 Feb; 35(2):418-27. PubMed ID: 15657954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.
    Fröhlich M; Gogishvili T; Langenhorst D; Lühder F; Hünig T
    Eur J Immunol; 2016 Jul; 46(7):1644-55. PubMed ID: 27122236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death by neglect as a deletional mechanism of peripheral tolerance.
    Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
    Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation.
    Yu XZ; Martin PJ; Anasetti C
    J Immunol; 2003 Mar; 170(6):3002-6. PubMed ID: 12626553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response.
    Demirci G; Gao W; Zheng XX; Malek TR; Strom TB; Li XC
    J Immunol; 2002 May; 168(9):4382-90. PubMed ID: 11970980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
    Vacchio MS; Hodes RJ
    J Immunol; 2005 Apr; 174(8):4657-61. PubMed ID: 15814689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis.
    Sfikakis PP; Zografou A; Viglis V; Iniotaki-Theodoraki A; Piskontaki I; Tsokos GC; Sfikakis P; Choremi-Papadopoulou H
    Arthritis Rheum; 1995 May; 38(5):649-54. PubMed ID: 7538295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
    Harding FA; Allison JP
    J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlike CD4+ T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity.
    Seah SG; Carrington EM; Ng WC; Belz GT; Brady JL; Sutherland RM; Hancock MS; La Gruta NL; Brown LE; Turner SJ; Zhan Y; Lew AM
    Eur J Immunol; 2012 Jul; 42(7):1744-54. PubMed ID: 22585421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Behar SM; Porcelli SA; Beckman EM; Brenner MB
    J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells.
    Ronchetti S; Nocentini G; Bianchini R; Krausz LT; Migliorati G; Riccardi C
    J Immunol; 2007 Nov; 179(9):5916-26. PubMed ID: 17947665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.
    Barbon CM; Davies JK; Voskertchian A; Kelner RH; Brennan LL; Nadler LM; Guinan EC
    Am J Transplant; 2014 Feb; 14(2):305-18. PubMed ID: 24410845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.